Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2003
06/03/2003US6573055 Immunoglobulin for use in the detection of preferential proteins in bodily fuids of mammals
06/03/2003US6573003 Soluble recombinant fusion protein comprising a nontoxin protein sequence and portion of Clostridium difficile toxin B amino acid sequence 10; pseudomembranous enterocolitis; side effect free; low cost
06/03/2003US6572857 Psoriasis; humanized sub clone of IOR T1A produced by the hybridoma deposited with ECACC, CAMR under accession number 96112640, having heavy and light chains with humanized variable regions.
06/03/2003US6572856 Classic complement pathway, C3 convertase
06/03/2003US6572852 Genetic engineering
06/03/2003US6572767 Simulated activity of Protein A displayed by ligands attached to a cellulose bead surface
06/03/2003CA2217633C Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
05/2003
05/30/2003WO2003044535A1 Method, antigen and antibody for distinguishing viable and apoptotic cells
05/30/2003WO2003044529A1 Modulators of lymphocyte activation, mkk3b compositions and methods of use
05/30/2003WO2003044482A2 Recombinant antibody fusion proteins and methods for detection of apoptotic cells
05/30/2003WO2003044224A1 Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer
05/30/2003WO2003044198A1 Artificial antibody library with super-repertory
05/30/2003WO2003044175A2 Methods and use of motoneuronotropic factors
05/30/2003WO2003044172A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003WO2003044170A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044058A2 Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis
05/30/2003WO2003044054A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
05/30/2003WO2003044036A1 Tumor specific monoclonal antibodies
05/30/2003WO2003043583A2 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003WO2003043566A2 Hip1 cancer markers
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003025565A3 Preparation of highly-purified plasma membranes
05/30/2003WO2003015817A3 Oral immunoglobulin treatment for inflammatory bowel disease
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003006055A3 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
05/30/2003WO2002102853A3 Cd4-specific antibody trx1 and uses therefor
05/30/2003WO2002100898A3 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002100328A3 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
05/30/2003WO2002088176A3 Genes and proteins for the biosynthesis of polyketides
05/30/2003WO2002077029A3 Cd19-specific redirected immune cells
05/30/2003WO2002076501A3 Blood cell production via activation of the hemoglobin scavenger receptor
05/30/2003WO2002076499A3 Combination treatment of pancreatic cancer
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002034290A9 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
05/30/2003WO2001091792A3 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
05/30/2003WO2001087922A3 Derivatisation of proteins in aqueous solution
05/30/2003CA2467459A1 Hip1 cancer markers
05/30/2003CA2467242A1 Treatment of immunological disorders using anti-cd30 antibodies
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467020A1 Tumor specific monoclonal antibodies
05/30/2003CA2464542A1 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/29/2003US20030101482 Compositions encoding lepidopteran-toxic polypeptides and methods of use
05/29/2003US20030100942 Hydrogel for the therapeutic treatment of aneurysms
05/29/2003US20030100746 Methods and materials relating to fibulin-like polypeptides and polynucleotides
05/29/2003US20030100741 Immunoglobulin protein for use in the treatment and prevention of viral infections and diseasee; viricides
05/29/2003US20030100529 Detecting a signal resulting from specifically hybridizing a tissue with a nucleic acid probe that contains a (anti)sense portion of kalinin/laminin 5 gamma-2 chain nucleic acid sequence
05/29/2003US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100490 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus
05/29/2003US20030100489 For determining if a subject is at risk for a disorder characterized by unwanted cell proliferation
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100483 As preservatives; in prophylaxis and therapy of viral or microbial infection in animals and plants, and in inactivating endotoxin
05/29/2003US20030100126 Antibody for use in the diagnosis of diabetic disorders
05/29/2003US20030100112 Expression vector for use as tool in the expression of exogenous nucleotide sequences in eukaryotic cells
05/29/2003US20030100095 New human cathepsin
05/29/2003US20030100091 Metalloprotease-disintegrin ADAM23 (SVPH3-17)
05/29/2003US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay
05/29/2003US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100071 Polypeptide for use in the prevention and treatment of bacterial infections
05/29/2003US20030100062 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases
05/29/2003US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100060 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE)
05/29/2003US20030100058 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
05/29/2003US20030100039 Novel human phospholipase c delta 5
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030100023 Immunoassay and antibody selection methods using cell surface expressed libraries
05/29/2003US20030100016 Complement C3 precursor biopolymer markers predictive of Alzheimers disease
05/29/2003US20030100015 Protein biopolymer markers indicative of age matched control
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030100013 HP biopolymer markers predictive of insulin resistance
05/29/2003US20030100012 Plasma protease C1 biopolymer markers predictive of alzheimers disease
05/29/2003US20030100011 IG lambda biopolymer markers predictive of alzheimers disease
05/29/2003US20030100010 Fibrinogen biopolymer Marker predictive of type II diabetes
05/29/2003US20030100009 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/29/2003US20030099994 Novel FDRG protein and nucleic acid molecules and uses therefor
05/29/2003US20030099992 Genes associated with mast cell activation
05/29/2003US20030099980 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, and inflammamtory diseases
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099934 Envelope protein for use in the treatment and prevention of viral diseases
05/29/2003US20030099931 Prophylactic and therapeutic monoclonal antibodies
05/29/2003US20030099662 Proteins
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099655 Humanized collagen antibodies and related methods
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099653 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099651 Method and pharmaceutical composition for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
05/29/2003US20030099650 Treatment of immune disorders and B cell disorders
1 ... 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 ... 1494